Navamedic News and Activities

Navamedic is a company listed under the stock ticker NAVA (NO).

Navamedic has a direct presence in 2 countries.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 25 main executives

Most searched biographies at Navamedic

• Lars Minor, Chief Executive Officer
• Mads Helmich Pedersen, Director
• Camilla Harder Hartvig, Director

Popular executive movements at Navamedic

• Nils Ole Krekling will join the company as Chief Financial Officer on Jan. 1, 2026  (posted on December 8 2025).
• Lars Hjarrand, Chief Financial Officer, will leave the company in Jan. 2026  (posted on December 8 2025).

Create your alert
to follow the executive moves at Navamedic.

Navamedic has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Navamedic

• Navamedic ASA: Change in leadership - Navamedic
• News archive - Navamedic
• Erhållen MDR-certifiering säkerställer kontinuitet av distribution för doseringsapparaten MyFID vid behandling av Parkinsons sjukdom | Navamedic
• Navamedic ASA: Invitation to 2022 4th quarter presentation | Navamedic

Social media about Navamedic

• Navamedic on Wikipedia, Google News & Yahoo Finance
• Navamedic on LinkedIn, X (Twitter) & YouTube